{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "19707559",
  "DateCompleted": {
    "Year": "2010",
    "Month": "01",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2009",
        "Month": "08",
        "Day": "26"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e6778",
      "10.1371/journal.pone.0006778"
    ],
    "Journal": {
      "ISSN": "1932-6203",
      "JournalIssue": {
        "Volume": "4",
        "Issue": "8",
        "PubDate": {
          "Year": "2009",
          "Month": "Aug",
          "Day": "26"
        }
      },
      "Title": "PloS one",
      "ISOAbbreviation": "PLoS One"
    },
    "ArticleTitle": "Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection.",
    "Pagination": {
      "StartPage": "e6778",
      "MedlinePgn": "e6778"
    },
    "Abstract": {
      "AbstractText": [
        "Although B. bronchiseptica efficiently infects a wide range of mammalian hosts and efficiently spreads among them, it is rarely observed in humans. In contrast to the many other hosts of B. bronchiseptica, humans are host to the apparently specialized pathogen B. pertussis, the great majority having immunity due to vaccination, infection or both. Here we explore whether immunity to B. pertussis protects against B. bronchiseptica infection. In a murine model, either infection or vaccination with B. pertussis induced antibodies that recognized antigens of B. bronchiseptica and protected the lower respiratory tract of mice against three phylogenetically disparate strains of B. bronchiseptica that efficiently infect na\u00efve animals. Furthermore, vaccination with purified B. pertussis-derived pertactin, filamentous hemagglutinin or the human acellular vaccine, Adacel, conferred similar protection against B. bronchiseptica challenge. These data indicate that individual immunity to B. pertussis affects B. bronchiseptica infection, and suggest that the high levels of herd immunity against B. pertussis in humans could explain the lack of observed B. bronchiseptica transmission. This could also explain the apparent association of B. bronchiseptica infections with an immunocompromised state."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, Pennsylvania, USA."
          }
        ],
        "LastName": "Goebel",
        "ForeName": "Elizabeth M",
        "Initials": "EM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zhang",
        "ForeName": "Xuqing",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Harvill",
        "ForeName": "Eric T",
        "Initials": "ET"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 AI053075",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI053075-04",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI053075-05",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI053075-03",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 GM083113",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "GM083113",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI053075-02",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS One",
    "NlmUniqueID": "101285081",
    "ISSNLinking": "1932-6203"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, Bacterial"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Antigens, Bacterial"
    },
    {
      "QualifierName": [
        "microbiology",
        "prevention & control"
      ],
      "DescriptorName": "Bordetella Infections"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Bordetella bronchiseptica"
    },
    {
      "QualifierName": [
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "Bordetella pertussis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice, Inbred C57BL"
    }
  ],
  "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist."
}